Social distancing has resulted in the cancellation of most public fundraising events, but the kids, families and researchers supported C2CAC/CCCF cannot social distance from cancer.
BREAKAWAY is a solo cycling challenge that raises funds for children with cancer across Canada and supports programming like the new childhood cancer COVID-19 Emergency Fund. Experienced and leisure riders, supporters, and families from coast to coast. Anyone can participate and unite in this fun and worthwhile adventure. Jump on the bike and ride with purpose this July and August!
We may not be together – but we can ride, have fun, and support kids with cancer.
Support a team or join yourself. Challenges for experienced cyclists, recreational cyclists and families.
1. Register and get your SWAG pack sent right to your door.
2. Earn badges when you complete challenges! Pick challenges that match your experience level – Challenge Road / Fun Ave / Family Lane (or do all of them!)
3. Invite friends and family to join you.
4. Fundraise online for the Foundation programs like the COVID-19 Emergency Fund
5. Connect to #breakawaykidscancer on Instagram and tag @childhoodcancer and @beyondkidscancer. You can also search Breakaway Kids Cancer and join our club on Strava to earn weekly bragging rights!
Nominations and submission can be made at the following link
Celebrates the leadership qualities of an early career paediatrician and recognizes their exceptional contribution and commitment to advocating for child and youth health at the regional level.
Current recipient: Dr. Stacey Marjerrison (pediatric hematologist/oncologist, Medical Director of the Oncology AfterCare Program at McMaster Children’s Hospital).
The candidate must be a paediatrician and member of the Canadian Paediatric Society and have been in practice 10 years or less. Current voting members of the CPS Board of Directors and Membership Subcommittee members are not eligible to be nominated for the award.
The membership Subcommittee, in collaboration with the board member(s) for the region will judge candidates based on their leadership and commitment in the three following areas:
- Patient Care (e.g., initiatives to improve the care of children and youth in their region; family-centred care focus; recognition of underserved/at-risk population and action to improve accessibility; innovative knowledge-to-practice initiatives)
- Community Service (e.g. contribution to making their community more active, safe, and child and youth-friendly; advocacy at local/provincial/territorial and/or national level; volunteer or administrative leadership positions)
- Teaching and Education (positive role model or mentor for junior trainees; leadership in public education; commitment to improving professional development for colleagues; spirit of scholarship)
There will be a maximum of one award per region per year. The regions are:
- British Columbia and Yukon
- Alberta and Northwest Territories
- Manitoba and Nunavut
- New Brunswick and PEI
- Nova Scotia
- Newfoundland and Labrador
- Letter of nomination from a CPS member specifically emphasizing how the candidate meets the criteria.
- Letter of support from a seconder affirming how the candidate meets the criteria. This seconder may be an individual from another discipline or sector.
- Updated CV for the nominee
The award is presented at a local meeting in the recipient’s community and announced at the Annual General Meeting of the CPS members.
Registration is require a minimum of 24 hour before the session; registration information has been posted to Igloo (available to your CRAs) and forwarded to your COG PI. Sessions will be run by Zoom or Microsoft Teams.
|Jul 08||Regulatory Binder||12:00-13:00 EST|
|Jul 10||CTCAE Criteria Adverse Events Training||12:00-13:00 EST|
|Jul 10||CTEP AERS training||14:00-14:30 EST|
|Jul 14||Health Canada Division 5 Regulations||12:00-13:00 EST|
|Jul 15||Informed Consent||12:30-13:30 EST|
|Jul 17||Oncology 101 (re-cast)||12:30-13:30 EST|
|Jul 21||RECIST 1.1 Criteria||12:30-13:30 EST|
|Jul 28||How to Read a Protocol||10:00-11:00 EST|
|Jul 22||Disease Site Training: Colon Cancers (re-cast)||12:30-13:30 EST|
- Slots are now available on the solid tumour cohort (and ALL, NHL) for venetoclax (with cyclo/topotecan)
- OZM-077 (carboplatin/azacitidine) study has now been amended to permit enrolment of patients with CNS or solid tumours other than ependymoma in expansion phase
- RET inhibitor study is now open
- New neuroblastoma study (aurora kinase inhibitor) is now open
Please note that despite COVID-19 restrictions, all NAIT studies continue to be open to enrollment
Studies for which funding is likely to be available from the trial itself are indicated in the table in the newsletter. For more information, please email: email@example.com
Please note that study status can change frequently and information above may become out of date. Please contact us to discuss currently availability for potential patients.
Helping families navigate:
To assist patients and families with their transition, our Patient Navigator Program will collaborate with your team and the family to provide assistance with issues related to travel, accommodation, and navigating their way around the hospital and in the city. Furthermore, for patients living outside of Ontario, our Patient Navigator will assist physicians in completing an Out-of-Province Prior Approval Application to the Provincial Ministry of Health. Please contact us for more information.
BOOKMARK NAIT: The current list of all open trials can be found on the NAIT Website at http://www.sickkids.ca/HaematologyOncology/nait/trials/index.html
The vision of the New Agents and Innovative Therapy Program (NAIT) supports The Garron Cancer Centre and Sick Kids’ commitment to innovation and providing Canadian children and their families living with cancer with greater access to the best and newest treatment that will assist to improve clinical care.
The C17 Council is searching for a Co-Chair for the C17 Nursing Administration committee. The successful co-Chair will support the following objectives of the committee:
- Collaborate nationally within C17 to strengthen the delivery of Pediatric (children, adolescents, young adults) Hematology/Oncology/BMT patient care by:
- Enhance abilities for communities of practice: Nursing Leadership, Nurse Educators, Advanced Practice Nurses and Nurse Practitioners, Social Work
- Supporting patient safety related to process improvement and best practice; sharing quality improvement and safety initiatives
- Tracking trends in human resources for the purpose of strategic planning
- Benchmarking across the country to assess adherence to relevant standards and practices
- Supporting quality work environments
- Supporting partnerships with external groups (COG, APHON, SIOP, CANO, POGO)
The Co-Chair will work closely with the Co-Chair and be co-responsible for budgets, decisions of the committee, attendance on Council teleconferences and meetings. The Co-Chair, C17 Nursing committee will serve a term of 3 years, renewable once. (After two terms, a new election will be called, but does not exclude any incumbent from standing for additional terms).
Requirements: Nurse interested in working with the C17 Council
Interested in working with the C17 Council and Canadian health professionals on nursing initiatives in the area of pediatric and AYA oncology, hematology and bone marrow transplant
Deadline: Nominations will be accepted until 22 June 2020
Nominations may be submitted by an individual interested in the position or a member of C17 to Dr. Conrad Fernandez, Chair of the C17 Nomination Committee and Kathy Brodeur-Robb, Executive Director, C17 Council, by email at Conrad.firstname.lastname@example.org and email@example.com.
The nominee must indicate that they accept the nomination, provide a brief description of their qualifications, vision and goals for the position, and provide a copy of their CV. Nominations will be accepted until the deadline listed. The position will be voted on by the C17 Council.
Full posting and application link here: https://www.careers.ualberta.ca/Competition/A100842455/
Assistant Professor, Division of Pediatric Immunology, Hematology/Oncology, Palliative Care and Environmental Health (iHOPE)
Faculty of Medicine – Pediatrics
Competition No. – A100842455
Closing Date – Will remain open until filled.
The University of Alberta, Faculty of Medicine & Dentistry, in partnership with Alberta Health Services (AHS) invites applicants to apply for a position of Clinical Assistant Professor with clinical activities focused as a Pediatric Hematologist within the Division of Pediatric Immunology, Hematology/Oncology, Palliative Care and Environmental Health (iHOPE) in the Department of Pediatrics.
Depending upon the qualifications and experience of the applicant, this position will be comprised of clinical service (50-65%) in hematology and thrombosis with the remainder of time allocated to academic pursuits: either teaching and/or research. Research can be in any area within Pediatric Hematology/Oncology. Contributions to education at the undergraduate and postgraduate levels are expected from all faculty members.
Interested applicants, must hold an MD and must have completed a subspecialty residency in Pediatric Hematology/Oncology, and be certified or eligible to become a fellow of the Royal College of Physicians and Surgeons of Canada (Pediatric Hematology/Oncology).
Remuneration for this position will be commensurate with qualifications and experience and will be based on the income scale of a competitive and highly successful academic alternate funding plan.
Adam Fleming’s challenge page – https://p2p.onecause.com/snippingforhope/adam-fleming
Make your home hair cutting experience have an impact for children living with cancer. Join the online #SnippingForHope!
We have all become a little shaggy during these unprecedented times, but why not make your home hair cutting experience have an impact for children living with cancer?
Join as an individual or a team at: hope.ctcacf.org
Join the challenge and shave or cut your hair at home, either by yourself or by a willing family member, and encourage your friends and family to donate to Childhood Cancer Canada.
Kids across Canada are still having to fight Cancer and unfortunately new children are being diagnosed. These children and their families still need our support during this time.
At Childhood Cancer Canada we support children and their families through a variety of programs and funding. Our programs range for Empower Packs, which are sent to newly diagnosed children, and the Survivorship Scholarship, given to young adult cancer survivors to pursue their post-secondary academic aspirations.
So join #SnippingForHope to help cancer families in a small but meaningful way.
The Cancer in Young People in Canada (CYP-C) program is looking for nominations for a Chair of the Management Committee
The Cancer in Young People in Canada (CYP-C) program is looking for nominations for a Chair of the Management Committee. CYP-C is the national pediatric oncology surveillance program that includes all children with cancer diagnosed since 2001. The program is a partnership between three key organizations, the Public Health Agency of Canada, C17 Council and the Canadian Partnership Against Cancer.
The CYP-C Management Committee makes decisions on behalf of the program based upon the perspectives of the three key organizations. It also implements recommendations from the CYP-C Advisory Committee. It is responsible for providing oversight for data currency and quality, providing clarifications or changes to the data elements, facilitating merger between Paediatric Oncology Group of Ontario Networked Information System and directly entered CYP-C data, reviewing research proposals and approving all CYP-C products such as reports. It also develops and promotes the Research Champions role. All activities are undertaken with a view to ensure representation from all 17 centres and from a variety of role types including nurses, researchers, Clinical Research Associates, pharmacists and other allied health staff. The committee meets monthly by teleconference and face-to-face annually.
The Management Committee Chair will also be a member of the Partners Group and an Ex officio member of the Advisory Committee. The Partners Group meets weekly by teleconference. The Chair will have the appropriate pediatric oncology, public health and research expertise and knowledge to carry out the necessary work and steer this Committee. The duration of a term is 3 years, and can be renewed once. A small stipend is provided in recognition of the work performed.
Please forward these requests to anyone to whom it may be of interest.
Names of interested candidates for either of these vacancies should be sent to the C17 Surveillance Co-ordinator, Randy Barber (firstname.lastname@example.org).
Deadline for nominations is July 1, 2020.
CYP-C Management Committee Chair
The primary responsibility of the CYP-C Management Committee Chair is to provide leadership to the CYP-C Management Committee. In consultation with the Public Health Agency of Canada (PHAC), the Chair sets the monthly agenda and develops priorities for the Committee throughout the year. The Chair is responsible for providing input into Committee membership, ensuring Committee milestones are met and that goals remain consistent with those of the CYP-C Partners. The Chair is responsible for scientific reviews of data applications and amendments, including assignment of reviewers, chairing review discussions and summarizes the review for the applicant. The Management Committee meets monthly.
The CYP-C Management Committee Chair is a member of the Partner’s Group. The Chair works with PHAC, the Canadian Partnership Against Cancer (CPAC) and the Pediatric Oncology Group of Ontario (POGO) to address questions and challenges in day-to-day operations of the program. Responsibilities include providing input into the financial structure of the program, data quality checks including mapping between POGONIS and CYP-C and development of data tools and products. The Partner’s group meets weekly. The CYP-C Surveillance Coordinator supports all activities.
The CYP-C Management Committee Chair is a member of the Advisory Committee. The Chair and PHAC are responsible for setting the agenda, preparing materials for Advisory Committee review, and presenting CYP-C progress. The Chair is responsible for communicating the recommendations from the Advisory Committee to the Partner’s Group and the Management Committee, and in consultation with PHAC, making decisions about their implementation.
The CYP-C Surveillance Coordinator supports the activities of the Management Committee, Partner’s Group and Advisory Committee.
Qualification of CYP-C Management Committee Chair
- Clinician who manages children with cancer
- Must be familiar with pediatric oncology cancer care in Canada
- Must be familiar with data relevant to pediatric oncology
- Must be familiar with privacy and security considerations related to data
- Must have excellent communication skills